August 2013 FDA Recall Drug by Cubist Pharmaceuticals, Inc.
D-764-2014 - Presence of Particulate Matter; Glass particulates observed in vials

This Class I drug recall was voluntarily initiated by Cubist Pharmaceuticals, Inc. on August 29, 2013 for the product Drug. The FDA reported the reason for recall as presence of particulate matter; glass particulates observed in vials. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-764-2014

Reason for Recall
Presence of Particulate Matter; Glass particulates observed in vials
Initiated
08-29-2013
Reported
01-29-2014
Quantity
179,870 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Cubist Pharmaceuticals, Inc.
Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA

Batch or Lot Expiration Information

Lot# Lot Numbers: Lot 950453F, Exp. 12/06/2013 Lot 090203F, Exp. 09/07/2014 Lot 201703F, Exp. 08/31/2015 Lot 201653F, Exp. 09/01/2015